VP/GM Clinical at Illumina

San Diego, California, United States

Illumina Logo
Not SpecifiedCompensation
Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
Biotechnology, Healthcare, GenomicsIndustries

Skills

Key technologies and capabilities for this role

Clinical Business DevelopmentGlobal StrategyOperating PlansGo-to-Market StrategyR&D Pipeline ManagementClinical Assay DevelopmentWorkflow SolutionsBusiness Process DesignStakeholder ManagementPartnership BuildingRegulatory AffairsQuality AssuranceOperations ManagementCommercial Strategy

Questions & Answers

Common questions about this position

What is the employment type for this VP/GM Clinical role?

This is a full-time position.

What are the key responsibilities for building the clinical business organization?

Responsibilities include developing a multi-year global strategy, leading cross-functional teams for go-to-market plans, executing an innovative R&D pipeline, collaborating with R&D functions, building partnerships, designing business processes, ensuring compliance, and fostering global collaboration.

What leadership responsibilities does the VP/GM Clinical role entail?

The role involves building organizational capability for clinical workflow solutions, establishing a culture of shared accountability focused on patient impact, compliance, and operational excellence, championing cross-functional collaboration, and developing talent and future leaders.

What is the company culture like at Illumina?

Illumina fosters a culture where every person has the opportunity to make a difference, surrounded by extraordinary people, inspiring leaders, and world-changing projects, with an emphasis on shared accountability, patient impact, compliance, and operational excellence.

What makes a strong candidate for the VP/GM Clinical position at Illumina?

Strong candidates will have experience leading cross-functional teams, developing global strategies, building R&D pipelines, ensuring regulatory compliance, fostering collaboration across functions, and developing talent in a clinical or genomic technology environment.

Illumina

Supports genomics startups through funding and resources

About Illumina

Illumina focuses on fostering innovation in the genomics industry by supporting startups through its Illumina Accelerator program. This program helps entrepreneurs create, launch, and grow genomics-focused companies by providing funding and resources. The accelerator operates in two main locations: the San Francisco Bay Area and Cambridge, UK. Illumina Accelerator has successfully invested in 68 genomics startups, which have collectively raised over $1 billion in venture capital. What sets Illumina apart from its competitors is its strong partnership with leading venture capital investors and its dedicated focus on the genomics sector. The goal of Illumina is to build a thriving ecosystem for genomics innovation, enabling new companies to emerge and advance the field.

San Diego, CaliforniaHeadquarters
1998Year Founded
$27.2MTotal Funding
IPOCompany Stage
Venture Capital, BiotechnologyIndustries
5,001-10,000Employees

Risks

Over-reliance on NVIDIA's AI technology may limit flexibility in AI solution adoption.
Standardizing proteomics data across platforms could challenge Illumina's data reliability.
Single-flow-cell NovaSeq X System might cannibalize sales of higher-end models.

Differentiation

Illumina leads in genomic sequencing with advanced AI integration and multiomic data analysis.
The company offers innovative array-based solutions for DNA, RNA, and protein analysis.
Illumina's global expansion includes a new Global Capability Center in Bengaluru.

Upsides

Collaboration with NVIDIA enhances drug discovery and clinical development through AI integration.
Pilot proteomics program with UK Biobank aims to generate crucial reference datasets.
Single-cell sequencing kits make high-throughput sequencing accessible to smaller labs.

Land your dream remote job 3x faster with AI